Background: Copper dyshomeostasis has been implicated in a subset of Alzheimer’s disease (AD) patients, characterized by elevated non-ceruloplasmin-bound copper (non-Cp Cu). This evidence concerns the gene CP and early-onset autosomal dominant Alzheimer disease.